Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherCLINICAL INVESTIGATIONS

Differential Diagnosis of Parkinson’s Disease and Vascular Parkinsonism by 99mTc-TRODAT-1

Kai-Yuan Tzen, Chin-Song Lu, Tzu-Chen Yen, Shiaw-Pyng Wey and Gann Ting
Journal of Nuclear Medicine March 2001, 42 (3) 408-413;
Kai-Yuan Tzen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chin-Song Lu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tzu-Chen Yen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiaw-Pyng Wey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gann Ting
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The aim of this study was to use brain SPECT to differentiate vascular parkinsonism (VP) from Parkinson’s disease. Methods: Fourteen VP patients (age range, 59–87 y; mean age, 70 ± 7.5 y), 30 Parkinson’s disease patients (age range, 54–84 y; mean age, 65 ± 8.8 y), and 26 healthy (control) individuals (age range, 50–85 y; mean age, 60 ± 9 y) were examined. A 925-MBq (25 mCi) dose of 99mTc-TRODAT-1 was injected intravenously, and brain SPECT images were acquired 4 h after injection. The ratio of specific to nonspecific striatal 99mTc-TRODAT-1 binding was measured and compared. Results: After a region-of-interest analysis of the images from VP patients, Parkinson’s disease patients, and healthy volunteers was performed to obtain ratios of putamen to occipital and striatal to occipital binding as a measurement of specific binding to the dopamine transporters in these regions of the brain, where dopamine neurons are concentrated, the specific binding in the 14 VP patients was slightly lower than but not statistically different from that of the healthy individuals in both putamen and caudate areas. A significant decrease in uptake of 99mTc-TRODAT-1 in the striatum (P < 0.01) was found in Parkinson’s disease patients. Reduction of the uptake was more pronounced in the contralateral putamen of Parkinson’s disease patients than that of VP patients (P < 0.001). A significant bilateral striatal asymmetry was also observed in Parkinson’s disease patients but not in VP patients (P < 0.01). Conclusion: Our findings clearly show that, for VP patients, 99mTc-TRODAT-1 SPECT is a reliable method to differentiate VP from Parkinson’s disease. Further studies, including those to differentiate Parkinson’s disease from arteriosclerotic parkinsonism and patients with both VP and Parkinson’s disease, are needed to help rule out the possibility of Parkinson’s disease as early as possible.

  • Parkinson’s disease
  • vascular parkinsonism
  • 99mTc-TRODAT-1

Footnotes

  • Received Jun. 5, 2000; revision accepted Sep. 29, 2000.

    For correspondence or reprints contact: Kai-Yuan Tzen, MD, Department of Nuclear Medicine, Chang Gung Memorial Hospital, 199, Tung-Hwa North Road, Taipei, 105 Taiwan.

View Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 3
March 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Differential Diagnosis of Parkinson’s Disease and Vascular Parkinsonism by 99mTc-TRODAT-1
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Differential Diagnosis of Parkinson’s Disease and Vascular Parkinsonism by 99mTc-TRODAT-1
Kai-Yuan Tzen, Chin-Song Lu, Tzu-Chen Yen, Shiaw-Pyng Wey, Gann Ting
Journal of Nuclear Medicine Mar 2001, 42 (3) 408-413;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Differential Diagnosis of Parkinson’s Disease and Vascular Parkinsonism by 99mTc-TRODAT-1
Kai-Yuan Tzen, Chin-Song Lu, Tzu-Chen Yen, Shiaw-Pyng Wey, Gann Ting
Journal of Nuclear Medicine Mar 2001, 42 (3) 408-413;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The role of DAT-SPECT in movement disorders
  • Combination of Converging Collimators for High-Sensitivity Brain SPECT
  • 123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Cerebrovascular Disease and Clinical Diagnosis of Vascular Parkinsonism
  • Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects
  • 99mTc-TRODAT-1 Imaging of Multiple System Atrophy
  • Dopamine Transporter Concentration Is Reduced in Asymptomatic Machado-Joseph Disease Gene Carriers
  • Evaluation of Early-Stage Parkinson's Disease with 99mTc-TRODAT-1 Imaging
  • Google Scholar

More in this TOC Section

  • Diagnostic Performance of Attenuation-Corrected Myocardial Perfusion Imaging for Coronary Artery Disease: A Systematic Review and Meta-Analysis
  • Clinical Evaluation of Zero-Echo-Time Attenuation Correction for Brain 18F-FDG PET/MRI: Comparison with Atlas Attenuation Correction
  • Absolute Myocardial Blood Flow and Flow Reserve Assessed by Gated SPECT with Cadmium–Zinc–Telluride Detectors Using 99mTc-Tetrofosmin: Head-to-Head Comparison with 13N-Ammonia PET
Show more Clinical Investigations

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire